Immuno-Biological Laboratories Co (TSE:4570) 3-Year EBITDA Growth Rate : 0.00% (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co 3-Year EBITDA Growth Rate?

Immuno-Biological Laboratories Co's EBITDA per Share for the three months ended in Mar. 2025 was 円0.00.

During the past 12 months, Immuno-Biological Laboratories Co's average EBITDA Per Share Growth Rate was 76.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Immuno-Biological Laboratories Co was 32.20% per year. The lowest was -454.20% per year. And the median was -11.60% per year.

Competitive Comparison of Immuno-Biological Laboratories Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immuno-Biological Laboratories Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Immuno-Biological Laboratories Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Immuno-Biological Laboratories Co (TSE:4570) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Immuno-Biological Laboratories Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuno-Biological Laboratories Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005

Website

http://www.ibl-japan.co.jp

Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines